AAAAAA

   
Results: 1-9 |
Results: 9
Stroke genomics: Approaches to identify, validate, and understand ischemicstroke gene expression
Authors: Read, SJ Parsons, AA Harrison, DC Philpott, K Kabnick, K O'Brien, S Clark, S Brawner, M Bates, S Gloger, I Legos, JJ Barone, FC
Citation: Sj. Read et al., Stroke genomics: Approaches to identify, validate, and understand ischemicstroke gene expression, J CEREBR B, 21(7), 2001, pp. 755-778
Inhibition of p38 mitogen-activated protein kinase provides neuroprotection in cerebral focal ischemia
Authors: Barone, FC Irving, EA Ray, AM Lee, JC Kassis, S Kumar, S Badger, AM Legos, JJ Erhardt, JA Ohlstein, EH Hunter, AJ Harrison, DC Philpott, K Smith, BR Adams, JL Parsons, AA
Citation: Fc. Barone et al., Inhibition of p38 mitogen-activated protein kinase provides neuroprotection in cerebral focal ischemia, MED RES REV, 21(2), 2001, pp. 129-145
Coadministration of methylprednisolone with hypertonic saline solution improves overall neurological function and survival rates in a chronic model of spinal cord injury
Authors: Legos, JJ Gritman, KR Tuma, RF Young, WF
Citation: Jj. Legos et al., Coadministration of methylprednisolone with hypertonic saline solution improves overall neurological function and survival rates in a chronic model of spinal cord injury, NEUROSURGER, 49(6), 2001, pp. 1427-1433
Tonicity of resuscitative fluids influences outcome after spinal cord injury
Authors: Sumas, ME Legos, JJ Nathan, D Lamperti, AA Tuma, RF Young, WF
Citation: Me. Sumas et al., Tonicity of resuscitative fluids influences outcome after spinal cord injury, NEUROSURGER, 48(1), 2001, pp. 167-172
SB 239063, a second-generation p38 mitogen-activated protein kinase inhibitor, reduces brain injury and neurological deficits in cerebral focal ischemia
Authors: Barone, FC Irving, EA May, AM Lee, JC Kassis, S Kumar, S Badger, AM White, RF McVey, MJ Legos, JJ Erhardt, JA Nelson, AH Ohlstein, EH Hunter, AJ Ward, K Smith, BR Adams, JL Parsons, AA
Citation: Fc. Barone et al., SB 239063, a second-generation p38 mitogen-activated protein kinase inhibitor, reduces brain injury and neurological deficits in cerebral focal ischemia, J PHARM EXP, 296(2), 2001, pp. 312-321
SB 239063, a novel p38 inhibitor, attenuates early neuronal injury following ischemia
Authors: Legos, JJ Erhardt, JA White, RF Lenhard, SC Chandra, S Parsons, AA Tuma, RF Barone, FC
Citation: Jj. Legos et al., SB 239063, a novel p38 inhibitor, attenuates early neuronal injury following ischemia, BRAIN RES, 892(1), 2001, pp. 70-77
Expression of PEP-19 inhibits apoptosis in PC12 cells
Authors: Erhardt, JA Legos, JJ Johanson, RA Slemmon, JR Wang, XK
Citation: Ja. Erhardt et al., Expression of PEP-19 inhibits apoptosis in PC12 cells, NEUROREPORT, 11(17), 2000, pp. 3719-3723
Quantitative changes in interleukin proteins following focal stroke in therat
Authors: Legos, JJ Whitmore, RG Erhardt, JA Parsons, AA Tuma, RF Barone, FC
Citation: Jj. Legos et al., Quantitative changes in interleukin proteins following focal stroke in therat, NEUROSCI L, 282(3), 2000, pp. 189-192
Nonpeptide tachykinin receptor antagonists. II. Ppharmacological and pharmacokinetic profile of SB-222200, a central nervous system penetrant, potentand selective NK-3 receptor antagonist
Authors: Sarau, HM Griswold, DE Bush, B Potts, W Sandhu, P Lundberg, D Foley, JJ Schmidt, DB Webb, EF Martin, LD Legos, JJ Whitmore, RG Barone, FC Medhurst, AD Luttmann, MA Giardina, GAM Hay, DWP
Citation: Hm. Sarau et al., Nonpeptide tachykinin receptor antagonists. II. Ppharmacological and pharmacokinetic profile of SB-222200, a central nervous system penetrant, potentand selective NK-3 receptor antagonist, J PHARM EXP, 295(1), 2000, pp. 373-381
Risultati: 1-9 |